Literature DB >> 29657150

Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.

Angelica Nangit1,2, Connie Lin1,2, Mariko L Ishimori1,2, Brennan M R Spiegel1,2, Michael H Weisman3,4.   

Abstract

OBJECTIVE: We investigated characteristics of adult patients with systemic lupus erythematosus (SLE) readmitted to the hospital within 30 days of discharge, in an attempt to identify the causes of early readmission.
METHODS: We performed a retrospective case-control study examining all inpatient electronic health records of patients with SLE at Cedars-Sinai Medical Center over a 2.5-year period (2012-2014). Patients were included if they had an International Classification of Diseases, 9th ed diagnosis of SLE and were readmitted within 30 days of their initial hospitalization. Patients with SLE not readmitted during this time period were used as a control group. Demographic and clinical variables for each patient were collected, and we used the Charlson Comorbidity Index to characterize comorbidities. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) was used to assess the chronic damage of SLE. Stepwise multivariable logistic regression analysis was used to predict factors associated with readmission.
RESULTS: In total, 570 hospitalizations representing 455 unique patients met our inclusion and exclusion criteria. Of these, 154 patients (34%) underwent readmission within 30 days of their initial hospitalization. Patients in the early readmission group were more likely to have government-sponsored Medicaid insurance and were significantly associated with an increased SDI (OR 1.27, 95% CI 1.1-1.48), lower serum hemoglobin (OR 0.82, 95% CI 0.72-0.93), and lower serum albumin (OR 0.66, 95% CI 0.47-0.91).
CONCLUSION: One-third of hospitalized patients with SLE were readmitted within 30 days at our institution. We identified characteristics of this at-risk population at time of discharge with high specificity, in hopes of reducing this costly outcome.

Entities:  

Keywords:  HOSPITAL READMISSION; READMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS

Mesh:

Substances:

Year:  2018        PMID: 29657150     DOI: 10.3899/jrheum.170176

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study.

Authors:  Rayan Najjar; Swetha A Alexander; Grant C Hughes; Jinoos Yazdany; Namrata Singh
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-19       Impact factor: 5.178

2.  One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days.

Authors:  Christie M Bartels; Ann Chodara; Yi Chen; Xing Wang; W Ryan Powell; Fangfang Shi; Maria Schletzbaum; Ann M Sheehy; Farah A Kaiksow; Andrea L Gilmore-Bykovskyi; Shivani Garg; Menggang Yu; Amy J Kind
Journal:  Semin Arthritis Rheum       Date:  2021-02-19       Impact factor: 5.431

3.  Prevalence of hospital readmissions and related factors in patients with autoimmune diseases.

Authors:  Tatiana Morales-Tisnés; Lina Quintero-Ortiz; Elías Quintero-Muñoz; Fabio Sierra-Matamoros; Julián Arias-Aponte; Adriana Rojas-Villarraga
Journal:  J Transl Autoimmun       Date:  2021-09-08

4.  Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.

Authors:  Alexandra Legge; Susan Kirkland; Kenneth Rockwood; Pantelis Andreou; Sang-Cheol Bae; Caroline Gordon; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Daniel J Wallace; Sasha Bernatsky; Ann E Clarke; Joan T Merrill; Ellen M Ginzler; Paul R Fortin; Dafna D Gladman; Murray B Urowitz; Ian N Bruce; David A Isenberg; Anisur Rahman; Graciela S Alarcón; Michelle Petri; Munther A Khamashta; M A Dooley; Rosalind Ramsey-Goldman; Susan Manzi; Asad A Zoma; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; S Sam Lim; Murat Inanc; Ronald F van Vollenhoven; Andreas Jonsen; Ola Nived; Manuel Ramos-Casals; Diane L Kamen; Kenneth C Kalunian; Søren Jacobsen; Christine A Peschken; Anca Askanase; John G Hanly
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-02-17       Impact factor: 5.178

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.